Merocar 1 gm/vial (IV Injection or Infusion)
Medicine Details
Category | Details |
---|---|
Generic | Meropenem trihydrate |
Company | Globe pharmaceuticals ltd |
Also available as |
Indications
- Pneumonia and Nosocomial Pneumonia
- Urinary Tract Infections
- Intra-abdominal Infections
- Gynaecological Infections
- Skin and Skin Structure Infections
- Meningitis
- Septicaemia
- Pulmonary infections in cystic fibrosis
- Empiric treatment for presumed infections in patients with febrile neutropenia
Pharmacology
Exerts bactericidal action by interfering with bacterial cell wall synthesis and shows potent activity against a broad spectrum of bacteria.
Dosage
- Adults:
- 500 mg to 1 gm by intravenous administration every 8 hours
- varied doses for specific infections
- Children:
- 10 to 40 mg/kg intravenously every 8 hours
- varied doses for specific infections
Administration
Should be administered by intravenous infusion over approximately 15-30 minutes or as intravenous bolus over approximately 3-5 minutes
Interaction
- Competes with probenecid for active tubular secretion
- May reduce serum valproic acid levels
Contraindications
Contraindicated in patients with demonstrated hypersensitivity to the product
Side Effects
- Inflammation
- Thrombophlebitis
- Pain at injection site
- Skin reactions like rash, pruritus, urticaria
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
Pregnancy & Lactation
Pregnancy Category B; should be used during pregnancy only if clearly needed. Caution should be exercised when administered to a nursing woman.
Precautions & Warnings
- Discontinue if allergic reaction occurs
- Use with careful monitoring in patients with hepatic disease
Use in Special Populations
- Renal impairment: Dosage should be reduced in patients with creatinine clearance less than 51 ml/min
- Hepatic impairment: No dosage adjustments necessary
- Elderly: No dosage adjustments necessary unless creatinine clearance is less than 51 ml/min
- Efficacy and tolerability in infants under 3 months not established
Overdose Effects
Accidental overdose could occur, treatment should be symptomatic; rapid renal elimination will occur in normal individuals, haemodialysis needed in subjects with renal impairment
Therapeutic Class
Other beta-lactam Antibiotics
Reconstitution
Preparation of solution for intravenous bolus and infusion administration, compatibility with various infusion fluids
Storage Conditions
Store in a cool, dry place (below 30°C), away from light & moisture; keep out of the reach of children.
Related Brands
- Admero 1 gm/vial (IV Injection or Infusion) - ad-din-pharmaceuticals-ltd
- Admero 500 mg/vial (IV Injection or Infusion) - ad-din-pharmaceuticals-ltd
- Merocil 250 mg/vial (IV Injection or Infusion) - pharmacil-limited
- G-Meropenem 1 gm/vial (IV Injection or Infusion) - gonoshasthaya-pharma-ltd
- G-Meropenem 500 mg/vial (IV Injection or Infusion) - gonoshasthaya-pharma-ltd